Boehringer Ingelheim (three new analgesic candidates) is Buildings and Property in Germany that focus on selective somatostatin business. They cover business area such as provider, treatment, inflammatory, neuropathic and mixed pain, potent, class.
-
Selective Somatostatin
-
Ingelheim am Rhein
Germany
Private
providertreatmentinflammatory, neuropathic and mixed painpotentclass
* We use standard office opening hours in near Boehringer Ingelheim (three new analgesic candidates)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Boehringer Ingelheim (three New Analgesic Candidates) is Buildings and Property business from Germany that founded in - ( years old in ), Boehringer Ingelheim (three new analgesic candidates) business is focusing on Selective Somatostatin.
Boehringer Ingelheim (three new analgesic candidates) headquarter office and corporate office address is located in Ingelheim am Rhein Germany.
Boehringer Ingelheim (three new analgesic candidates) was founded in Germany.
In , Boehringer Ingelheim (three new analgesic candidates) is currently focus on selective somatostatin sector.
Above is snippet of Google Trends for "selective somatostatin" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Boehringer Ingelheim (three new analgesic candidates), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
